Navigation Links
Investor Group Commends Clint Severson for Joining Trinity Biotech's Board of Directors
Date:11/20/2008

KANSAS CITY, Mo., Nov. 20 /PRNewswire/ -- An investor group in Trinity Biotech plc (Nasdaq: TRIB), an Irish based developer and manufacturer of diagnostic products whose shares are traded in the form of American Depository Receipts on NASDAQ, is encouraged that Clint Severson has joined the company's board of directors.

Commenting on the news, Tom Reidy stated, "We are delighted that Clint has agreed to serve as an independent director, bringing the total of independent directors to two. While Clint's appointment is a step in the right direction, we continue to believe that the election of an independent director controlled board is essential to an increase in company share value. We look forward to Clint remaining as part of our new board immediately following our pending action to remove and replace the current board."

In October, the investor group directed that Trinity Biotech shareholders be given the opportunity to vote on a slate of replacement directors, including Mr. Severson. The remaining proposed slate consists of the following individuals:

     1. Dr. Jack C. Chow, M.D., M.B.A. -- Partner, CRV Capital, LLC and
        adjunct professor at Carnegie Mellon University's Heinz School of
        Public Policy and Management;
     2. Mr. Mike Gausling -- Managing Partner, Originate Ventures;
     3. Dr. John H. Halsey, Ph.D. -- Chief Executive Officer, Director,
        Founder, ProGene Biomedical, Inc. (dba IBT Laboratories);
     4. Mr. Steven A. Mock, CPA -- Partner, BKD, LLP; and
     5. Mr. Thomas Reidy.

Further commenting on the appointment of Mr. Severson, Tom Reidy stated that 'based on several conversations with Mr. Severson, I believe we are totally aligned on the aspects of effective corporate governance, transparency of board and company actions, and performance-based remuneration programs. Clint's emphasis on management accountability and the need for sharp focus and effective strategic planning are essential in today's marketplace. We just need more people like Clint on the board '.


'/>"/>
SOURCE KC Investor Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. SXC Health Solutions to host analyst and institutional investor event
2. Unilever Investor Relations Seminar
3. ProAssurance to Present at Oppenheimer Investor Conference
4. Surgical Care Affiliates Announces Investor Conference Call to Discuss Third Quarter 2008 Results
5. Alexion to Present at Investor Conferences
6. Jazz Pharmaceuticals to Present at Investor Conferences
7. Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
8. BD to Present at Investor Healthcare Conferences
9. VirtualScopics to Present at Two Upcoming Investor Conferences
10. Pregis Announces Investor Conference Call to Review 2008 Third Quarter Financial Results
11. Robbins & Myers to Present at Sidoti & Company Investor Conference on November 10, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... Room (ER) on Wednesday, August 16, to community partners. The newly renovated ER ... “Fast Track” area for minor emergencies, eight semi-private rooms to deliver patient results, ...
(Date:8/17/2017)... ... 17, 2017 , ... An August 2 article on NextShark discusses ... largely influenced by the growing popularity of “pretty boys” in both K-Pop and television ... of male appearance are changing not only in the Asian nation, where plastic surgery ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... care professionals, today announced that it has raised $1.675 M in seed funding ... Rethink Education, Lumina Foundation, and Techstars Venture Capital Fund are the company’s primary ...
(Date:8/17/2017)... ... August 17, 2017 , ... Momkus McCluskey Roberts LLC ... Parks is a member of the firm’s Commercial Litigation and Employment Law groups. , ... wealth of knowledge in matters of employment litigation, commercial litigation and business disputes. Her ...
(Date:8/17/2017)... ... 2017 , ... Finalists in the 2017 (second annual) ... awards recognize the world’s best employers and the human resources professionals, teams, achievements ... to work. , A diverse group of organizations and individuals around the world ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
(Date:8/7/2017)... Insightin Health, provider of data-driven decision-making ... announced the selection of Michael Wood ... as of February 2017. In this role, Wood will ... our clients. Wood brings with him more than ... analytics within the healthcare industry. Wood formerly served ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) today ... effective Aug. 7, 2017. ... interests and will serve as president emeritus during a planned, ... in multiple leadership roles since he joined Diplomat with the ... provided decisive, strategic leadership which continues to benefit our patients ...
Breaking Medicine Technology: